LINC00473 rescues human bone marrow mesenchymal stem cells from apoptosis induced by dexamethasone through the PEBP1-mediated Akt/Bad/Bcl-2 signaling pathway
| Autor: | Yingxing Xu, Zhiping Zhao, Yaping Jiang, Tao Li, Yingzhen Wang |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Male dexamethasone Bone Marrow Cells Phosphatidylethanolamine Binding Protein lncRNA LINC00473 phosphatidylethanolamine-binding protein 1 03 medical and health sciences 0302 clinical medicine Downregulation and upregulation Genetics Humans education Protein kinase B Aged Akt/Bad/Bcl-2 signaling pathway education.field_of_study Oncogene Chemistry human bone marrow mesenchymal stem cells apoptosis Mesenchymal Stem Cells General Medicine Articles Middle Aged Molecular medicine 030104 developmental biology Phosphatidylethanolamine binding protein 1 Proto-Oncogene Proteins c-bcl-2 Apoptosis 030220 oncology & carcinogenesis Cancer research Phosphorylation Female RNA Long Noncoding bcl-Associated Death Protein Signal transduction Proto-Oncogene Proteins c-akt Signal Transduction |
| Zdroj: | International Journal of Molecular Medicine |
| ISSN: | 1791-244X 1107-3756 |
| Popis: | The inhibition of the proliferation and apoptosis of bone marrow-derived mesenchymal stem cells (BMSCs) triggered by the excessive use of glucocorticoids, is considered a potential mechanism for the pathogenesis of steroid-induced osteonecrosis of the femoral head (SONFH). Long non-coding RNAs (lncRNAs) have been proven to influence the proliferation, apoptosis and differentiation of BMSCs by regulating the expression of critical genes. A previous microarray analysis by the authors confirmed the significant downregulation of LINC00473 in human BMSCs (hBMSCs) from patients with SONFH. However, the underlying role and molecular mechanisms of LINC00473 on dexamethasone (Dex)-stimulated hBMSCs remains unknown. In the present study, the expression of LINC00473 was determined in the hBMSCs of patients with SONFH and control patients. In addition, the protective effects and underlying molecular mechanisms of LINC00473 in Dex-stimulated hBMSCs were investigated. The results revealed that LINC00473 expression was significantly down-regulated in hBMSCs from patients with SONFH compared with the controls, and that the upregulation of LINC00473 attenuated the inhibitory effects exerted by 1 µM Dex on the proliferation and apoptosis of hBMSCs. Moreover, the upregulation of LINC00473 significantly promoted the protein expression of phosphorylated (p-)Akt, p-Bcl-2-associated death promoter (p-Bad) and B-cell lymphoma 2 (Bcl-2), whereas it decreased the cleavage of caspase-3, thus preventing the Dex-induced apoptosis of hBMSCs. Of note, the regulatory effects of LINC00473 on the Akt/Bad/Bcl-2 signaling pathway and its anti-apoptotic effects were similar to those of SC79 (an Akt activator), and were inhibited by MK-2206 (an Akt inhibitor). In further experiments, it was found that the upregulation of LINC00473 markedly promoted the phosphorylation of Akt in Dex-stimulated hBMSCs, and increased the protein level of phosphatidylethanolamine-binding protein 1 (PEBP1). Alternatively, the promoting effect on Akt phosphorylation induced by LINC00473 was significantly attenuated following the knockdown of PEBP1. Furthermore, the upregulation of PEBP1 triggered a marked increase in the levels of Akt phosphorylation in Dex-stimulated hBMSCs, which was line with the upregulation of LINC00473. Taken together, the results of the present study demonstrate that LINC00473 has the ability to rescue hBMSCs from Dex-induced apoptosis through the PEBP1-mediated activation of the Akt/Bad/Bcl-2 signaling pathway. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|